Thursday, December 19, 2013
Publication and contact
Assays & screens
Monitoring cell-free DNA in
plasma to predict organ transplant rejection
Cell-free DNA in plasma
could be used to quantify viral load and predict risk of transplant
rejection. In plasma obtained from patients that received heart or lung
transplants, cell-free DNA was sequenced to identify changes in virus
populations and quantify viral load. The data were analyzed to find
correlations between antiviral and immunosuppressant regimes, viral load and
risk of organ rejection. Decreased burden of anellovirus post-transplantation
correlated with increased organ rejection, which was thought to reflect an
increased level of patient immunocompetence. Next steps include using the
method in larger patient cohorts and patients undergoing organ transplants
other than heart and lung.
Laboratories Inc. markets ImmuKnow,
an immune cell function assay that detects cell-mediated immune response in
patients undergoing immunosuppressive therapy for organ transplant.
Published online Dec. 19, 2013
Patent and licensing status
De Vlaminck, I. et al.
published online Nov. 21, 2013;
Contact: Stephen R. Quake, Stanford University, Stanford,
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]